Scotland · NHS Scotland MSAN
Danazol 100mg & 200mg capsules
MSAN(2020)44 · Level 3 · issued 01 Jun 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Danazol 100mg and 200mg capsules have been discontinued in the UK and remaining supplies | Discontinued | — |
| 8. Sanofi discontinued Danol (danazol) capsules from the UK market in December 2019 and supplies | Discontinued | — |
| pharmaceutical ingredient (API) which has led to the discontinuation of danazol capsules within | Discontinued | — |
| that are, licensed alternatives are available. There are greater concerns for patients prescribed | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2020:44
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
9c5f53919b4bb0efe595e6fa87ffd259d2f34cfeeb92dd9751d58ce3630183casha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2020-44.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.